Cailin Conner

DocwireNews

Patients with hyperuricemia or gout who were ambulatory had a higher likelihood of heart failure (HF) compared with those who did not have hyperuricemia or gout, according to a recent study published in the Journal of Translational Medicine.Utilizing data from the National Health and Nutrition Examination Survey conducted between 2001 and 2018, the study included data from non-pregnant participants aged &ge;20 years with or without hyperuricemia, gout, and HF. The researchers employed various statistical analyses, including binary logistic regression, Kaplan&ndash;Meier curve, Cox proportional-hazards model, and restricted cubic spline analysis, to assess the relationships among these conditions as well as all-cause mortality.Out of the weighted eligible participants (204,179,060 from 2001-2018 and 223,702,171 from 2007-2018), 19.6% had hyperuricemia, and 4.1% had gout. The study identified older age, diabetes, stroke, and coronary artery disease (CAD) as risk factors for HF in individuals with hyperuricemia and gout. The median survival time for patients with HF and hyperuricemia was 7.00 years, while for those with HF and gout, it was 6.25 years. The 5-year survival rate was 59.9% for HF patients with hyperuricemia and 55.9% for HF patients with gout.Additionally, the results of the study suggested that patients with hyperuricemia or gout were 2.46 and 2.35 times more likely to develop HF, respectively, compared with those without these conditions. Furthermore, patients with HF and hyperuricemia or gout had a 1.37- and 1.45-times higher risk of experiencing all-cause mortality.&ldquo;The present study,&rdquo; per the researchers, &ldquo;found that ambulatory patients with hyperuricemia, gout, or HF had a high burden of cardiometabolic comorbidities, including obesity, hypertension, diabetes, CAD, and stroke.&rdquo;However, the study had several limitations. Firstly, the uric acid levels were measured only once, failing to capture its dynamic nature influenced by dietary factors, potentially introducing bias. Secondly, due to limited data availability, not all potential confounding factors could be included in the analysis.Despite the limitations, the study&rsquo;s results offer crucial epidemiological evidence for recognizing modifiable risk factors and addressing the emerging dual epidemic of hyperuricemia, gout, and HF.Source: <a href="https://translational-medicine.biomedcentral.com/articles/10.1186/s12967-023-04307-z" target="_blank" rel="noopener">Journal of Translational Medicine</a>

Jordana Jampel

Positive Preliminary Results From Phase 1 Trial of Dopaminergic Neuron Graft for Parkinson’s Disease

Dementia

Bradley Warady, MD

Joel M. Topf, MD, FACP

2025 Hume Award Winner Is Dedicated to Children’s Care

NKF Spring Clinical Meetings 2025

Distant Brain Metastases in Cutaneous Melanoma May Be Mitigated With Multiple Pathway Inhibitors

Melanoma

Latest News

Increased Long-term Mortality Risk in Heart Failure Patients With Hyperuricemia, Gout

Gout

Hyperuricemia and gout were associated with a higher risk of long-term mortality in patients with heart failure.

Increased Long-term Mortality Risk in Heart Failure Patients With Hyperuricemia and Gout

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HER2 Breast Cancer

HR Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe